Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity

Journal of Biological Chemistry

Volumn 288, Issue 46, 2013, Pages 32886-32896

  Lee, Kyeong Won ^a   Cho, Jin Gu ^b   Kim, Chul Min ^b   Kang, A Young ^b   Kim, Min ^a   Ahn, Byung Yong ^a   Chung, Sung Soo ^a   Lim, Key Hwan ^b   Baek, Kwang Hyun ^b   Sung, Jong Hyuk ^b   Park, Kyong Soo ^a,c   Park, Sang Gyu ^b  

^a Seoul National University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COIMMUNOPRECIPITATION ANALYSIS; DE-UBIQUITINATING ACTIVITY; LUCIFERASE ACTIVITY ASSAYS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; QUANTITATIVE RT-PCR; SITE DIRECTED MUTAGENESIS; SPECIFIC INHIBITORS; TRANSCRIPTIONAL ACTIVITY;

CYTOLOGY; ENZYME ACTIVITY; GLUCOSE;

STABILITY;

FATTY ACID; GLUCOSE; HERPESVIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID TRANSPORT; GENE TARGETING; GLUCOSE TRANSPORT; IMMUNOPRECIPITATION; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RESIDUE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

DEUBIQUITINATION; DIABETES; GLUCOSE METABOLISM; METABOLISM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR);

ADENOVIRIDAE; AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD GLUCOSE; CERCOPITHECUS AETHIOPS; COS CELLS; FATTY ACIDS; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HEP G2 CELLS; HUMANS; INDENES; MALE; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PPAR GAMMA; PROTEIN STABILITY; PYRAZINES; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; UBIQUITIN THIOLESTERASE; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION;

EID: 84887838822     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.496331     Document Type: Article

References (48)

1. Desvergne, B., and Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649-688
2. Lehrke, M., and Lazar, M. A. (2005) The many faces of PPARγ. Cell 123, 993-999
3. van Beekum, O., Fleskens, V., and Kalkhoven, E. (2009) Post-translational modifications of PPAR-γ: fine-tuning the metabolic master regulator. Obesity 17, 213-219
4. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A., and Chatterjee, V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132
5. Camp, H. S., and Tafuri, S. R. (1997) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase.J. Biol. Chem. 272, 10811-10816
6. Camp, H. S., Tafuri, S. R., and Leff, T. (1999) c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity. Endocrinology 140, 392-397
7. Hu, E., Kim, J. B., Sarraf, P., and Spiegelman, B. M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103
8. Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., and Moller, D. E. (1996) Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ. J. Biol. Chem. 271, 31771-31774
9. Iankova, I., Petersen, R. K., Annicotte, J. S., Chavey, C., Hansen, J. B., Kratchmarova, I., Sarruf, D., Benkirane, M., Kristiansen, K., and Fajas, L. (2006) Peroxisome proliferator-activated receptor γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Mol. Endocrinol. 20, 1494-1505
10. Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Boström, P., Laznik, D., Ruas, J. L., Chalmers, M. J., Kamenecka, T. M., Blüher, M., Griffin, P. R., and Spiegelman, B. M. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466, 451-456
11. Ohshima, T., Koga, H., and Shimotohno, K. (2004) Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification. J. Biol. Chem. 279, 29551-29557
12. Chung, S. S., Ahn, B. Y., Kim, M., Kho, J. H., Jung, H. S., and Park, K. S. (2011)SUMOmodification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes. Biochem. J. 433, 155-161
13. Hauser, S., Adelmant, G., Sarraf, P., Wright, H. M., Mueller, E., and Spiegelman, B. M. (2000) Degradation of the peroxisome proliferatoractivated receptor γ is linked to ligand-dependent activation. J. Biol. Chem. 275, 18527-18533
14. Floyd, Z. E., and Stephens, J. M. (2002) Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes. J. Biol. Chem. 277, 4062-4068
15. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., and Gu, W. (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653
16. Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., and Vogelstein, B. (2004) Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428, 1 page following 486
17. Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya- Feldstein, J., and Pandolfi, P. P. (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813-817
18. van der Horst, A., de Vries-Smits, A. M., Brenkman, A. B., van Triest, M. H., van den Broek, N., Colland, F., Maurice, M. M., and Burgering, B. M. (2006) FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 8, 1064-1073
19. van der Knaap, J. A., Kumar, B. R., Moshkin, Y. M., Langenberg, K., Krijgsveld, J., Heck, A. J., Karch, F., and Verrijzer, C. P. (2005)GMPsynthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 17, 695-707
20. Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J., Lee, W., Edwards, A. M., Arrowsmith, C. H., and Frappier, L. (2005) Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18, 25-36
21. Chung, S. S., Kim, M., Youn, B. S., Lee, N. S., Park, J. W., Lee, I. K., Lee, Y. S., Kim, J. B., Cho, Y. M., Lee, H. K., and Park, K. S. (2009) Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferatoractivated receptor γ in human skeletal muscle cells. Mol. Cell. Biol. 29, 20-30
22. Kase, E. T., Wensaas, A. J., Aas, V., Højlund, K., Levin, K., Thoresen, G. H., Beck-Nielsen, H., Rustan, A. C., and Gaster, M. (2005) Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 54, 1108-1115
23. Lim, S., Ahn, B. Y., Chung, S. S., Park, H. S., Cho, B. J., Kim, M., Choi, S. H., Lee, I. K., Lee, S. W., Choi, S. J., Chung, C. H., Cho, Y. M., Lee, H. K., and Park, K. S. (2009) Effect of a peroxisome proliferator-activated receptor γ sumoylation mutant on neointimal formation after balloon injury in rats. Atherosclerosis 206, 411-417
24. Jennewein, C., Kuhn, A. M., Schmidt, M. V., Meilladec-Jullig, V., von Knethen, A., Gonzalez, F. J., and Brüne, B. (2008) Sumoylation of peroxisome proliferator-activated receptor - by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from B-binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 181, 5646-5652
25. Li, M., Brooks, C. L., Kon, N., and Gu, W. (2004)Adynamic role ofHAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886
26. Kilroy, G. E., Zhang, X., and Floyd, Z. E. (2009) PPAR-γ AF-2 domain functions as a component of a ubiquitin-dependent degradation signal. Obesity 17, 665-673
27. Christianson, J. L., Nicoloro, S., Straubhaar, J., and Czech, M. P. (2008) Stearoyl-CoA desaturase 2 is required for peroxisome proliferator- activated receptor - expression and adipogenesis in cultured 3T3-L1 cells. J. Biol. Chem. 283, 2906-2916
28. Waite, K. J., Floyd, Z. E., Arbour-Reily, P., and Stephens, J. M. (2001) Interferon-γ-induced regulation of peroxisome proliferator-activated receptor γ and STATs in adipocytes. J. Biol. Chem. 276, 7062-7068
29. Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., Calabrese, A., Borg-Capra, C., Sippl, W., Collura, V., Boissy, G., Rain, J. C., Guedat, P., Delansorne, R., and Daviet, L. (2009) Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol. Cancer Ther. 8, 2286-2295
30. Cummins, J. M., and Vogelstein, B. (2004) HAUSP is required for p53 destabilization. Cell Cycle 3, 689-692
31. Rahimian, R., Masih-Khan, E., Lo, M., van Breemen, C., McManus, B. M., and Dubé, G. P. (2001) Hepatic overexpression of peroxisome proliferatoractivated receptor γ2 in the ob/ob mouse model of noninsulin dependent diabetes mellitus. Mol. Cell. Biochem. 224, 29-37
32. Yamazaki, T., Shiraishi, S., Kishimoto, K., Miura, S., and Ezaki, O. (2011) An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. J. Nutr. Biochem. 22, 543-553
33. Matsusue, K., Haluzik, M., Lambert, G., Yim, S. H., Gavrilova, O., Ward, J. M., Brewer, B., Jr., Reitman, M. L., and Gonzalez, F. J. (2003) Liverspecific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111, 737-747
34. Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A., Moser, A. H., Grunfeld, C., and Feingold, K. R. (2000) Up-regulation of peroxisome proliferator-activated receptors (PPAR-γ) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141, 4021-4031
35. Bedoucha, M., Atzpodien, E., and Boelsterli, U. A. (2001) Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J. Hepatol. 35, 17-23
36. Laplante, M., Sell, H., MacNaul, K. L., Richard, D., Berger, J. P., and Deshaies, Y. (2003) PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52, 291-299
37. Nagashima, K., Lopez, C., Donovan, D., Ngai, C., Fontanez, N., Bensadoun, A., Fruchart-Najib, J., Holleran, S., Cohn, J. S., Ramakrishnan, R., and Ginsberg, H. N. (2005) Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J. Clin. Invest. 115, 1323-1332
38. Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., and Shi, Y. (2006) Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 4, e27
39. DuBois, R. N., Gupta, R., Brockman, J., Reddy, B. S., Krakow, S. L., and Lazar, M. A. (1998) The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis 19, 49-53
40. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B. M. (1998) Terminal differentiation of human breast cancer through PPARγ. Mol. Cell 1, 465-470
41. Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X. P., Eng, C., Spiegelman, B. M., and Kantoff, P. W. (2000) Effects of ligand activation of peroxisome proliferator- activated receptor γ in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 10990-10995
42. Kinzler, K. W., and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170
43. Núñez, N. P., Liu, H., and Meadows, G. G. (2006) PPAR-γ ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. Cancer Lett. 236, 133-141
44. Keshamouni, V. G., Reddy, R. C., Arenberg, D. A., Joel, B., Thannickal, V. J., Kalemkerian, G. P., and Standiford, T. J. (2004) Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in nonsmall-cell lung cancer. Oncogene 23, 100-108
45. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., and Evans, R. M. (2001) PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52
46. Palakurthi, S. S., Aktas, H., Grubissich, L. M., Mortensen, R. M., and Halperin, J. A. (2001) Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation. Cancer Res. 61, 6213-6218
47. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G., Ming, U. T., Baird, S. M., Thomazy, V. A., and Evans, R. M. (1998) Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat. Med. 4, 1058-1061
48. Lefebvre, A. M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J. C., Geboes, K., Briggs, M., Heyman, R., and Auwerx, J. (1998) Activation of the peroxisome proliferator-activated receptor - promotes the development of colon tumors in C57BL/6J-APCMin/- mice. Nat. Med. 4, 1053-1057